Grant directory
Travel & financial grants
Grants covering travel, lodging, meals, caregiver support, and direct financial assistance tied to specific conditions. 2,109 programs indexed.
BMS Access Support
UnknownUnder review·Jul 29, 2026Details →BMS Access Support
UnknownUnder review·Jul 29, 2026Details →BMS Access Support
UnknownBristol-Myers Squibb
Under review·Mar 18, 2026Details →BMS Access Support
UnknownBristol-Myers Squibb
The BMS Access Support program offers co-pay and financial assistance for eligible patients prescribed specific BMS medications, helping with deductibles, co-pays, or co-insurance. This program does not provide assistance for travel-related expenses such as flights, hotels, or gas.
Under review·Mar 14, 2026Details →BMS Access Support - ONUREG (azacitidine) Patient Assistance Program
UnknownBristol-Myers Squibb
financial assistanceUnder review·Mar 16, 2026Details →BMS Access Support Patient Assistance Program
UnknownBristol-Myers Squibb
financial assistanceUnder review·Jul 29, 2026Details →BMS Patient Assistance Program
UnknownBristol-Myers Squibb
financial assistanceUnder review·Jul 29, 2026Details →BMS Patient Assistance Program
UnknownBristol-Myers Squibb
The content provided is unreadable, making it impossible to determine what the grant covers or who qualifies. The grant is offered by Bristol-Myers Squibb as part of their patient assistance program.
financial assistanceUnder review·Jul 29, 2026Details →BMS Patient Assistance Program
UnknownUnder review·Jul 29, 2026Details →BMS Patient Assistance Program (Istodax)
UnknownBristol-Myers Squibb
financial assistanceUnder review·Jul 29, 2026Details →BMS Patient Support Co-pay Assistance
UnknownUnder review·Jul 29, 2026Details →Boston Children's Hospital Cystic Fibrosis Patient Resources
UnknownThis page provides a comprehensive list of patient resources for individuals with cystic fibrosis, including educational materials, peer support groups, and wellness programs. However, it does not contain information about a specific patient travel assistance grant from Boston Children's Hospital or details on financial aid for travel expenses.
caregiver supportUnder review·May 4, 2026Details →Bosulif Copay Card
UnknownPfizer
The Bosulif Co-Pay Card is a financial assistance program provided by Pfizer for eligible, commercially insured patients taking BOSULIF (bosutinib). It helps patients pay as little as $0 a month for their prescription, with a maximum benefit of $9,450 per use. To qualify, patients must be 18 or older, live in the US or Puerto Rico, have private commercial insurance, and not be enrolled in federal or state prescription drug programs like Medicare or Medicaid, nor be cash-paying.
financial assistanceUnder review·Jul 29, 2026Details →Bosulif Steps Program
UnknownPfizer
The Bosulif Steps Program is an assistance program provided by Pfizer for patients who take the medication Bosulif (Bosutinib). Specific details regarding covered services, eligibility, or whether it functions as a travel assistance grant are not available on this page.
transportationfinancial assistanceUnder review·Apr 24, 2026Details →Breast Cancer Solutions Resource Guide
UnknownUnder review·Mar 18, 2026Details →Bristol Myers Squibb Patient Assistance
UnknownBristol-Myers Squibb
The provided page content describes various patient assistance programs offered by Bristol Myers Squibb to help patients access and afford their prescribed medicines. These programs include help understanding insurance coverage, co-pay assistance for commercially insured patients, and free medication for eligible uninsured patients experiencing financial hardship. No information regarding a travel assistance grant is available on this page.
financial assistanceUnder review·Mar 16, 2026Details →Bristol Myers Squibb Patient Assistance Foundation Application
UnknownBristol Myers Squibb Patient Assistance Foundation
financial assistanceUnder review·Mar 14, 2026Details →Bristol Myers Squibb Patient Assistance Program
UnknownBristol-Myers Squibb
financial assistanceUnder review·Mar 17, 2026Details →Bristol Myers Squibb Patient Assistance Program
UnknownUnder review·Mar 20, 2026Details →Bristol Myers Squibb Patient Support and Co-pay Assistance
UnknownUnder review·Mar 20, 2026Details →Bristol-Myers Squibb Access Support
UnknownBristol-Myers Squibb
Under review·Jul 29, 2026Details →Bristol-Myers Squibb Patient Assistance Program Application Form
UnknownBristol-Myers Squibb
The grant details, including coverage type, income requirements, and maximum grant amount, cannot be determined from the provided raw PDF content. The document appears to be an application form for the Bristol-Myers Squibb Patient Assistance Program.
financial assistanceUnder review·Jul 29, 2026Details →Calquence Access 360
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →Canadian Epilepsy Alliance Transportation Assistance
Unknowntransportationfinancial assistanceUnder review·Jul 28, 2026Details →CancerCare Acute Lymphoblastic Leukemia Financial Assistance
UnknownUnder review·Jul 29, 2026Details →CancerCare Chronic Myeloid Leukemia Financial Assistance
UnknownUnder review·May 3, 2026Details →CancerCare Co-Payment Assistance Foundation
UnknownCancerCare Co-Payment Assistance Foundation
This grant, likely from CancerCare Co-Payment Assistance Foundation, appears to focus on financial assistance for co-payments and drug reimbursement, especially for myeloma patients, based on the provided URL. The available information does not explicitly indicate coverage for travel expenses.
financial assistanceUnder review·Mar 20, 2026Details →CancerCare Co-Payment Assistance Foundation and Drug Reimbursement Assistance
UnknownUnder review·Mar 20, 2026Details →CancerCare News Melanoma Patient Assistance Program
UnknownCancerCare
financial assistanceUnder review·Mar 18, 2026Details →CancerCare Transportation Assistance for Mesothelioma Patients Program
UnknownCancerCare
transportationfinancial assistanceUnder review·Jul 29, 2026Details →Caprelsa Financial Assistance Program
UnknownThe page content does not explicitly mention a "Caprelsa Financial Assistance Program" as a travel assistance grant. While it references "Exelixis Access Services (EASE)" for Cabometyx® (cabozantinib) treatment support, it does not specify any travel coverage or qualification criteria for this program.
financial assistanceUnder review·Mar 15, 2026Details →CGD Association Patient Assistance Program (PAP)
UnknownCGD Association
This is a patient assistance program provided by the CGD Association. Given the context of travel assistance grants, it is inferred to offer financial support for travel-related expenses to patients diagnosed with Chronic Granulomatous Disease (CGD).
financial assistanceUnder review·Mar 14, 2026Details →ChemoExperts Amivantamab (Rybrevant) Patient Assistance
UnknownUnder review·Mar 20, 2026Details →ChemoExperts Dasatinib Patient Assistance
UnknownChemoExperts
The page provides information about Dasatinib (Sprycel) treatment, not a specific travel assistance grant. It generally mentions that social workers can help patients locate resources such as grants or temporary housing. Additionally, it notes that some clinical trials may cover travel costs for participants, but this is not a program directly offered by ChemoExperts.
financial assistanceUnder review·Jul 29, 2026Details →ChemoExperts Eribulin (Halaven) Patient Assistance
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →ChemoExperts Patient Assistance and Copay Assistance
Unknownfinancial assistanceUnder review·Mar 18, 2026Details →ChemoExperts Patient Assistance for Capecitabine (Xeloda)
UnknownChemoExperts
This page provides comprehensive information about Capecitabine (Xeloda) treatment for Bile Duct Cancer, covering its schedule, side effects, and monitoring. While it mentions that social workers can help caregivers locate general resources like grants or temporary housing, and that some clinical trials may cover travel, the page does not detail a specific patient travel assistance grant offered directly by ChemoExperts.
financial assistanceUnder review·Mar 20, 2026Details →ChemoExperts Patient Assistance for Everolimus (Afinitor)
UnknownChemoExperts
The ChemoExperts Patient Assistance for Everolimus (Afinitor) page primarily provides information about the Everolimus drug itself, including its schedule, side effects, and monitoring. It broadly mentions patient assistance programs as a way to help reduce drug costs. However, the page does not explicitly state that this specific program offers travel assistance, temporary housing, or other direct financial aid, nor does it list specific qualifications for such assistance.
transportationfinancial assistanceUnder review·Apr 24, 2026Details →ChemoExperts Patient Assistance Program
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →ChemoExperts Patient Assistance Programs
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →ChemoExperts Patient Assistance Programs for Asciminib (Scemblix®)
UnknownUnder review·Jul 29, 2026Details →ChemoExperts Patient Assistance Programs for Fruzaqla
UnknownChemoExperts
financial assistanceUnder review·Mar 16, 2026Details →ChemoExperts Sunitinib (Sutent) Patient Assistance
UnknownUnder review·Mar 19, 2026Details →Chiesi Total Care Copay Assistance Program
UnknownUnder review·Mar 20, 2026Details →Chiesi Total Care Myalept Patient Support Services
UnknownChiesi
Under review·Mar 20, 2026Details →Chiesi Total Care Patient Support Program
UnknownChiesi
financial assistanceUnder review·Jul 29, 2026Details →Children's Health Medication Assistance Program
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →CINJ Patient Assistance Guide
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →CIRM Patient Assistance Program
Unknownfinancial assistanceUnder review·Jul 29, 2026Details →Clinical Trial Travel and Lodging Program
UnknownNational Organization for Rare Disorders (NORD)
This program provides financial assistance for travel and lodging expenses for patients participating in clinical trials. It is offered through the National Organization for Rare Disorders (NORD).
lodgingtransportationUnder review·Jul 29, 2026Details →